NEU neuren pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-5

  1. 547 Posts.
    lightbulb Created with Sketch. 1345
    what I have certainly observed in the last three months is that they have had problems in improving the contents of the US patent of 2591 and it is an out of place extension on the concession of the European one at the end of last June.in fact, in the period in question only the Japanese one came, making the fundamental intellectual potential incomplete to progress to the operational testing phase of 2591 incomplete.my belief is that this issue has also extended the time frame for the deal on which Torreya is working as it emerged in Treagus' last speech.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.